Pseudo-pseudo Meigs syndrome developed under the leflunomide therapy
Identifieur interne : 001834 ( Main/Exploration ); précédent : 001833; suivant : 001835Pseudo-pseudo Meigs syndrome developed under the leflunomide therapy
Auteurs : Cemal Bes [Turquie] ; Mehmet Soy [Turquie]Source :
- Rheumatology International [ 0172-8172 ] ; 2011-04-01.
English descriptors
- KwdEn :
Abstract
Abstract: Pseudo-pseudo Meigs syndrome or Tjalma syndrome is characterized by increased CA-125 level, pleural effusion and ascites in systemic lupus erythematosus (SLE) patients without over tumor. The disorder is relatively rare and it has been reported usually in SLE patients with impaired renal functions. Herein, we present a case of a 47-year-old female patient who developed Tjalma syndrome after administration of leflunomide for rheumatoid arthritis. Surprisingly renal functions of our patient were found in normal limits. This is the first case of Tjalma syndrome that is developed in normal renal functions and the probable role of leflunomide therapy is discussed.
Url:
DOI: 10.1007/s00296-009-1190-2
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000717
- to stream Istex, to step Curation: 000717
- to stream Istex, to step Checkpoint: 000759
- to stream Main, to step Merge: 001838
- to stream Main, to step Curation: 001834
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pseudo-pseudo Meigs syndrome developed under the leflunomide therapy</title><author><name sortKey="Bes, Cemal" sort="Bes, Cemal" uniqKey="Bes C" first="Cemal" last="Bes">Cemal Bes</name></author><author><name sortKey="Soy, Mehmet" sort="Soy, Mehmet" uniqKey="Soy M" first="Mehmet" last="Soy">Mehmet Soy</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:DD3A232165DAF51AD1FAD94496DED836E6625226</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1007/s00296-009-1190-2</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-VGV4FKKG-4/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000717</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000717</idno><idno type="wicri:Area/Istex/Curation">000717</idno><idno type="wicri:Area/Istex/Checkpoint">000759</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000759</idno><idno type="wicri:doubleKey">0172-8172:2009:Bes C:pseudo:pseudo:meigs</idno><idno type="wicri:Area/Main/Merge">001838</idno><idno type="wicri:Area/Main/Curation">001834</idno><idno type="wicri:Area/Main/Exploration">001834</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Pseudo-pseudo Meigs syndrome developed under the leflunomide therapy</title><author><name sortKey="Bes, Cemal" sort="Bes, Cemal" uniqKey="Bes C" first="Cemal" last="Bes">Cemal Bes</name><affiliation wicri:level="1"><country xml:lang="fr">Turquie</country><wicri:regionArea>Bolu</wicri:regionArea></affiliation><affiliation></affiliation></author><author><name sortKey="Soy, Mehmet" sort="Soy, Mehmet" uniqKey="Soy M" first="Mehmet" last="Soy">Mehmet Soy</name><affiliation wicri:level="1"><country xml:lang="fr">Turquie</country><wicri:regionArea>Bolu</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Rheumatology International</title><title level="j" type="sub">Clinical and Experimental Investigations</title><title level="j" type="abbrev">Rheumatol Int</title><idno type="ISSN">0172-8172</idno><idno type="eISSN">1437-160X</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Berlin/Heidelberg</pubPlace><date type="published" when="2011-04-01">2011-04-01</date><biblScope unit="volume">31</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="521">521</biblScope><biblScope unit="page" to="523">523</biblScope></imprint><idno type="ISSN">0172-8172</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0172-8172</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Leflunomide</term><term>SLE</term><term>Tjalma syndrome</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Pseudo-pseudo Meigs syndrome or Tjalma syndrome is characterized by increased CA-125 level, pleural effusion and ascites in systemic lupus erythematosus (SLE) patients without over tumor. The disorder is relatively rare and it has been reported usually in SLE patients with impaired renal functions. Herein, we present a case of a 47-year-old female patient who developed Tjalma syndrome after administration of leflunomide for rheumatoid arthritis. Surprisingly renal functions of our patient were found in normal limits. This is the first case of Tjalma syndrome that is developed in normal renal functions and the probable role of leflunomide therapy is discussed.</div></front></TEI><affiliations><list><country><li>Turquie</li></country></list><tree><country name="Turquie"><noRegion><name sortKey="Bes, Cemal" sort="Bes, Cemal" uniqKey="Bes C" first="Cemal" last="Bes">Cemal Bes</name></noRegion><name sortKey="Soy, Mehmet" sort="Soy, Mehmet" uniqKey="Soy M" first="Mehmet" last="Soy">Mehmet Soy</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001834 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001834 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:DD3A232165DAF51AD1FAD94496DED836E6625226
|texte= Pseudo-pseudo Meigs syndrome developed under the leflunomide therapy
}}
| This area was generated with Dilib version V0.6.33. |  |